Biotech

All Articles

Biogen, UCB document phase 3 lupus succeed after failing earlier trial

.Biogen and also UCB's bank on advancing into period 3 on the back of a failed study tries to have p...

Aptadir really hopes brand new RNA preventions may reverse difficult cancers cells

.Italian biotech Aptadir Rehabs has launched with the pledge that its own pipeline of preclinical RN...

Wave surfs DMD success to regulatory authorities' doors, sending out stock up

.Wave Lifestyle Sciences has actually met its own target in a Duchenne muscle dystrophy (DMD) resear...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma crease, ta...

Achilles trickles tissue treatment plan, prepares for discharges after overlooking 'commercial stability' objectives

.Achilles Rehabs has shreded its tactic. The English biotech is actually knocking off on its own cli...

Aligos trumpets period 2 MASH win, lowering liver fat approximately 46%

.Aligos Therapies is actually advertising a midstage succeed in metabolic-dysfunction affiliated ste...

Basilea scores $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work creating new antifungals has actually acquired a notable increase comi...

Capricor sells Europe legal rights to late-stage DMD therapy for $35M

.Possessing currently scooped up the USA civil rights to Capricor Rehabs' late-stage Duchenne muscle...

FDA junks adcomm for Applied's unusual illness drug

.After pushing the choice date for Applied Therapies' metabolic ailment medication govorestat, the F...

Novo inks $600M NanoVation deal to analyze hereditary medicines ex-liver

.Novo Nordisk is actually continuing its push into genetic medications, accepting to compensate Nano...